{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:49:43Z","timestamp":1788349783843,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000165","name":"Division of Chemistry","doi-asserted-by":"publisher","award":["CHE-1625735"],"award-info":[{"award-number":["CHE-1625735"]}],"id":[{"id":"10.13039\/100000165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS076517"],"award-info":[{"award-number":["R01NS076517"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MH096463"],"award-info":[{"award-number":["R01MH096463"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2321-B-002-001"],"award-info":[{"award-number":["NSTC 113-2321-B-002-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 111-2321-B-002-045"],"award-info":[{"award-number":["NSTC 111-2321-B-002-045"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2321-B-002-059"],"award-info":[{"award-number":["NSTC 112-2321-B-002-059"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2321-B-002-052"],"award-info":[{"award-number":["NSTC 113-2321-B-002-052"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.biopha.2025.118344","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T15:13:11Z","timestamp":1752592391000},"page":"118344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["\u03b16GABAA receptor positive allosteric modulators targeting trigeminal ganglia for preventing and aborting chronic periorbital allodynia and cephalic pain in both sexes: A mechanistic and comparative preclinical study"],"prefix":"10.1016","volume":"189","author":[{"given":"Xin-Chen","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7765-8171","authenticated-orcid":false,"given":"Chen-Jiun","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8524-7835","authenticated-orcid":false,"given":"Yi-Ting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2873-5466","authenticated-orcid":false,"given":"Yueh-Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dishary","family":"Sharmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5512-3022","authenticated-orcid":false,"given":"James","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-0046","authenticated-orcid":false,"given":"Yu-Cheng","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5356-940X","authenticated-orcid":false,"given":"Lih-Chu","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118344_bib1","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1097\/j.pain.0000000000002142","article-title":"Therapeutic targeting of nitroglycerin-mediated trigeminovascular neuronal hypersensitivity predicts clinical outcomes of migraine abortives","volume":"162","author":"Akerman","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2025.118344_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0306-4522(92)90256-2","article-title":"The distribution of binding by isolectin I-B4 from Griffonia simplicifolia in the trigeminal ganglion and brainstem trigeminal nuclei in the rat","volume":"47","author":"Ambalavanar","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2025.118344_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12325-023-02650-7","article-title":"Unmet needs in the acute treatment of migraine","volume":"41","author":"Bentivegna","year":"2024","journal-title":"Adv. Ther."},{"key":"10.1016\/j.biopha.2025.118344_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1526-4610.2011.01903.x","article-title":"Sex-related differences in animal models of migraine headache","volume":"51","author":"Bolay","year":"2011","journal-title":"Headache"},{"key":"10.1016\/j.biopha.2025.118344_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1744-8069-10-26","article-title":"A simplified up-down method (SUDO) for measuring mechanical nociception in rodents using von Frey filaments","volume":"10","author":"Bonin","year":"2014","journal-title":"Mol. Pain."},{"key":"10.1016\/j.biopha.2025.118344_bib6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.291.8.965","article-title":"Topiramate for migraine prevention: a randomized controlled trial","volume":"291","author":"Brandes","year":"2004","journal-title":"Jama"},{"key":"10.1016\/j.biopha.2025.118344_bib7","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.neuron.2017.10.028","article-title":"Ca(V)2.2 gates calcium-independent but voltage-dependent secretion in mammalian sensory neurons","volume":"96","author":"Chai","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2025.118344_bib8","article-title":"The pipeline and market for migraine drugs","author":"Chaudhari","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2025.118344_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12060851","article-title":"Deep learning-based grimace scoring is comparable to human scoring in a mouse migraine model","volume":"12","author":"Chiang","year":"2022","journal-title":"J. Pers. Med"},{"key":"10.1016\/j.biopha.2025.118344_bib10","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/bph.14198","article-title":"Cerebellar alpha6 -subunit-containing GABAA receptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders","volume":"175","author":"Chiou","year":"2018","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118344_bib11","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1177\/0333102419861726","article-title":"Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain","volume":"39","author":"Christensen","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.biopha.2025.118344_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ana.21897","article-title":"Triptan-induced latent sensitization: A possible basis for medication overuse headache","volume":"67","author":"De Felice","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2025.118344_bib13","article-title":"Pivotal role of Slitrk1 in adult striatal cholinergic neurons in mice: implication in tourette syndrome","author":"Du","year":"2023","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2025.118344_bib14","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1172\/JCI86812","article-title":"Local GABAergic signaling within sensory ganglia controls peripheral nociceptive transmission","volume":"127","author":"Du","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2025.118344_bib15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the target of new migraine therapies - successful translation from bench to clinic","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2025.118344_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0333102420963857","article-title":"No additive effect of combining sumatriptan and olcegepant in the GTN mouse model of migraine","volume":"41","author":"Ernstsen","year":"2021","journal-title":"Cephalalgia"},{"key":"10.1016\/j.biopha.2025.118344_bib17","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1093\/brain\/awac040","article-title":"The PACAP pathway is independent of CGRP in mouse models of migraine: possible new drug target?","volume":"145","author":"Ernstsen","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2025.118344_bib18","doi-asserted-by":"crossref","first-page":"1451634","DOI":"10.3389\/fphar.2024.1451634","article-title":"The deuterated pyrazoloquinolinone targeting alpha6 subunit-containing GABA(A) receptor as novel candidate for inhibition of trigeminovascular system activation: implication for migraine therapy","volume":"15","author":"Fan","year":"2024","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118344_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2018.07.017","article-title":"The \u03b16 subunit-containing GABA(A) receptor: a novel drug target for inhibition of trigeminal activation","volume":"140","author":"Fan","year":"2018","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.biopha.2025.118344_bib20","article-title":"Migraine","volume":"8","author":"Ferrari","year":"2022","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2025.118344_bib21","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/(SICI)1096-9861(19960212)365:3<504::AID-CNE12>3.0.CO;2-Q","article-title":"Immunocytochemical localization of the alpha 6 subunit of the gamma-aminobutyric acidA receptor in the rat nervous system","volume":"365","author":"Guti\u00e9rrez","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.biopha.2025.118344_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001958","article-title":"Dorsal root ganglia control nociceptive input to the central nervous system","volume":"21","author":"Hao","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.biopha.2025.118344_bib23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1460-9568.2006.04602.x","article-title":"A local GABAergic system within rat trigeminal ganglion cells","volume":"23","author":"Hayasaki","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118344_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12974-019-1459-7","article-title":"Microglial NLRP3 inflammasome activation mediates IL-1\u03b2 release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model","volume":"16","author":"He","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2025.118344_bib25","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/0333102411398399","article-title":"Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine","volume":"31","author":"Hewitt","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.biopha.2025.118344_bib26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrneurol.2010.127","article-title":"CGRP and its receptors provide new insights into migraine pathophysiology","volume":"6","author":"Ho","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2025.118344_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s13311-023-01342-y","article-title":"Cerebellar alpha6GABA(A) receptors as a therapeutic target for essential tremor: Proof-of-concept study with ethanol and pyrazoloquinolinones","volume":"20","author":"Huang","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2025.118344_bib28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1468-2982.2004.00726.x","article-title":"Safety, tolerability and pharmacokinetics of BIBN 4096 BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers","volume":"24","author":"Iovino","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.biopha.2025.118344_bib29","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/acs.jmedchem.7b01664","article-title":"Design and synthesis of novel deuterated ligands functionally selective for the \u03b3-aminobutyric acidtype A receptor (GABA(A)R) \u03b16 subtype with Improved metabolic stability and enhanced bioavailability","volume":"61","author":"Knutson","year":"2018","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2025.118344_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0026-895X(25)08539-6","article-title":"Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor","volume":"47","author":"Korpi","year":"1995","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2025.118344_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nmeth.1455","article-title":"Coding of facial expressions of pain in the laboratory mouse","volume":"7","author":"Langford","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biopha.2025.118344_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113022","article-title":"Targeting alpha6GABAA receptors as a novel therapy for schizophrenia: a proof-of-concept preclinical study using various animal models","volume":"150","author":"Lee","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118344_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2142\/biophysics.11.9","article-title":"Electrophysiological characteristics of IB4-negative TRPV1-expressing muscle afferent DRG neurons","volume":"11","author":"Lin","year":"2015","journal-title":"Biophys. (Nagoyashi"},{"key":"10.1016\/j.biopha.2025.118344_bib34","doi-asserted-by":"crossref","DOI":"10.3791\/62867","article-title":"Dural stimulation and periorbital von frey testing in mice as a preclinical model of headache","author":"Mason","year":"2021","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2025.118344_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4137\/JCNSD.S4365","article-title":"Topiramate: safety and efficacy of its use in the prevention and treatment of migraine","volume":"3","author":"Minton","year":"2011","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.biopha.2025.118344_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuropharm.2018.12.017","article-title":"Delta opioid receptor agonists are effective for multiple types of headache disorders","volume":"148","author":"Moye","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118344_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s10194-024-01753-y","article-title":"CGRP-targeted medication in chronic migraine - systematic review","volume":"25","author":"Oliveira","year":"2024","journal-title":"J. Headache Pain."},{"key":"10.1016\/j.biopha.2025.118344_bib38","article-title":"Long-term management of migraine with onabotulinumtoxinA (Botox) vs calcitonin gene-related peptide antibodies (Anti-CGRP)","volume":"15","author":"Pallapothu","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.biopha.2025.118344_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-physiol-030212-183717","article-title":"Pathophysiology of migraine","volume":"75","author":"Pietrobon","year":"2013","journal-title":"Annu Rev. Physiol."},{"key":"10.1016\/j.biopha.2025.118344_bib40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0306-4522(00)00442-5","article-title":"GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain","volume":"101","author":"Pirker","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2025.118344_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pain.2013.10.004","article-title":"Characterization of a novel model of chronic migraine","volume":"155","author":"Pradhan","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2025.118344_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/03331024231223971","article-title":"Calcitonin gene-related peptide receptor antagonism reduces motion sickness indicators in mouse migraine models","volume":"44","author":"Rahman","year":"2024","journal-title":"Cephalalgia"},{"key":"10.1016\/j.biopha.2025.118344_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12121612","article-title":"Gepants for acute and preventive migraine treatment: a narrative review","volume":"12","author":"Rissardo","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.biopha.2025.118344_bib44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1152\/jn.01007.2007","article-title":"Na+,K+,2Cl- cotransport and intracellular chloride regulation in rat primary sensory neurons: thermodynamic and kinetic aspects","volume":"100","author":"Rocha-Gonz\u00e1lez","year":"2008","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.biopha.2025.118344_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048005","article-title":"Trigeminal ganglion neurons of mice show intracellular chloride accumulation and chloride-dependent amplification of capsaicin-induced responses","volume":"7","author":"Schobel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118344_bib46","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pharmrev.121.000293","article-title":"\u03b16-containing GABA(a) receptors: functional roles and therapeutic potentials","volume":"74","author":"Sieghart","year":"2022","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.biopha.2025.118344_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/head.12034","article-title":"Migraine: the seventh disabler","volume":"53","author":"Steiner","year":"2013","journal-title":"Headache. J. Head. Face Pain."},{"key":"10.1016\/j.biopha.2025.118344_bib48","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1523\/JNEUROSCI.20-20-07531.2000","article-title":"Abnormal GABAA receptor-mediated currents in dorsal root ganglion neurons isolated from Na\u2013K\u20132Cl cotransporter null mice","volume":"20","author":"Sung","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118344_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/joa.13413","article-title":"The trigeminal system: the meningovascular complex- a review","volume":"239","author":"Terrier","year":"2021","journal-title":"J. Anat."},{"key":"10.1016\/j.biopha.2025.118344_bib50","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s13311-020-00951-1","article-title":"\u03b16GABA(A) receptor positive modulators alleviate migraine-like grimaces in mice via compensating GABAergic deficits in trigeminal ganglia","volume":"18","author":"Tzeng","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2025.118344_bib51","first-page":"147","article-title":"A simple in vitro method to study the trigeminal ganglion","volume":"49","author":"van Loveren","year":"1986","journal-title":"Appl. Neurophysiol."},{"key":"10.1016\/j.biopha.2025.118344_bib52","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/brain\/awac104","article-title":"Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine","volume":"145","author":"Watanabe","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2025.118344_bib53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12974-021-02342-5","article-title":"MicroRNA-155-5p promotes neuroinflammation and central sensitization via inhibiting SIRT1 in a nitroglycerin-induced chronic migraine mouse model","volume":"18","author":"Wen","year":"2021","journal-title":"J. Neuroinflamm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:49:13Z","timestamp":1777574953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225005384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":53,"alternative-id":["S0753332225005384"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118344","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b16GABAA receptor positive allosteric modulators targeting trigeminal ganglia for preventing and aborting chronic periorbital allodynia and cephalic pain in both sexes: A mechanistic and comparative preclinical study","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118344"}}